29.30
price down icon3.24%   -0.98
pre-market  プレマーケット:  29.05   -0.25   -0.85%
loading
前日終値:
$30.28
開ける:
$29.72
24時間の取引高:
727.59K
Relative Volume:
1.07
時価総額:
$1.71B
収益:
$32.87M
当期純損益:
$674.31M
株価収益率:
2.5792
EPS:
11.36
ネットキャッシュフロー:
$-330.11M
1週間 パフォーマンス:
-9.32%
1か月 パフォーマンス:
-17.56%
6か月 パフォーマンス:
-34.05%
1年 パフォーマンス:
+0.21%
1日の値動き範囲:
Value
$28.31
$29.83
1週間の範囲:
Value
$28.31
$32.12
52週間の値動き範囲:
Value
$27.14
$62.58

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
名前
Agios Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
617-649-8600
Name
住所
88 SIDNEY STREET, CAMBRIDGE, MA
Name
職員
488
Name
Twitter
@AgiosPharma
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
AGIO's Discussions on Twitter

AGIO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AGIO
Agios Pharmaceuticals Inc
29.30 1.71B 32.87M 674.31M -330.11M 11.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-24 開始されました H.C. Wainwright Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-10-10 再開されました Raymond James Outperform
2024-09-27 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-08 開始されました Cantor Fitzgerald Overweight
2023-02-03 開始されました Piper Sandler Overweight
2022-11-17 アップグレード Goldman Sell → Neutral
2022-07-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-12-03 開始されました BofA Securities Buy
2021-07-30 ダウングレード Goldman Neutral → Sell
2021-07-01 開始されました Raymond James Mkt Perform
2021-06-10 開始されました H.C. Wainwright Buy
2021-03-01 ダウングレード JP Morgan Overweight → Neutral
2021-03-01 アップグレード SVB Leerink Mkt Perform → Outperform
2021-02-26 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-10-22 アップグレード Barclays Equal Weight → Overweight
2020-03-04 開始されました Barclays Equal Weight
2019-11-26 開始されました Cantor Fitzgerald Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-05-23 再開されました Goldman Neutral
2019-02-15 アップグレード SVB Leerink Mkt Perform → Outperform
2018-09-25 開始されました Leerink Partners Mkt Perform
2018-05-23 開始されました Citigroup Buy
2018-04-11 繰り返されました Credit Suisse Outperform
2018-02-15 繰り返されました Needham Buy
2018-02-15 繰り返されました SunTrust Buy
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-08-10 繰り返されました Needham Buy
2017-08-08 繰り返されました SunTrust Buy
2017-08-02 アップグレード Leerink Partners Mkt Perform → Outperform
2017-06-26 ダウングレード Janney Buy → Neutral
2017-01-17 アップグレード Oppenheimer Perform → Outperform
2016-10-24 開始されました Needham Buy
2016-06-13 アップグレード JP Morgan Neutral → Overweight
2016-05-18 繰り返されました SunTrust Buy
すべてを表示

Agios Pharmaceuticals Inc (AGIO) 最新ニュース

pulisher
Mar 26, 2025

Is Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey

Mar 26, 2025
pulisher
Mar 24, 2025

First Week of November 21st Options Trading For Agios Pharmaceuticals (AGIO) - Nasdaq

Mar 24, 2025
pulisher
Mar 21, 2025

Agios Pharmaceuticals divulges new PAH stabilizers for phenylketonuria - BioWorld MedTech

Mar 21, 2025
pulisher
Mar 19, 2025

Beta Thalassemia Market Predicted to See Upsurge Through 2034, - openPR

Mar 19, 2025
pulisher
Mar 12, 2025

Agios Pharmaceuticals at Barclays Conference: Strategic Advances in Rare Disease Treatments - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Agios Pharm at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com Canada

Mar 11, 2025
pulisher
Mar 10, 2025

Q1 EPS Estimate for Agios Pharmaceuticals Lowered by Analyst - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

FY2027 Earnings Estimate for AGIO Issued By Zacks Research - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Agios Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer - The Manila Times

Mar 06, 2025
pulisher
Mar 05, 2025

Agios Pharmaceuticals Announces Inducement Equity Awards for New Executive - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate - EIN News

Mar 05, 2025
pulisher
Mar 05, 2025

Celldex Therapeutics and Agios Pharmaceuticals to Present at March 2025 Investor Conferences - Barchart

Mar 05, 2025
pulisher
Mar 05, 2025

Meet Agios' New Strategy Chief: Inside the $2M+ Executive Compensation Deal - Stock Titan

Mar 05, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals chief commercial officer sells $59,742 in stock By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals chief commercial officer sells $59,742 in stock - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Agios Pharmaceuticals CEO sells shares worth $460,135 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Agios to Present at Upcoming Investor Conferences - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Where to Hear Agios Management Next Month: Key Investor Conferences Revealed - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 - Star Tribune

Mar 01, 2025
pulisher
Mar 01, 2025

Is Agios Pharmaceuticals, Inc. (AGIO) the Best Small-Cap Stock to Buy Now? - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

Y Intercept Hong Kong Ltd Acquires Shares of 45,817 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

What is HC Wainwright's Estimate for AGIO Q1 Earnings? - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock rises - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

10 Best Small-Cap Stocks to Buy Now - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Gilbert Cisneros conducts multiple transactions in stocks including Agios Pharmaceuticals and Airbnb - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Sickle Cell Disease Market Growth Projections 2024-2034: - openPR

Feb 27, 2025
pulisher
Feb 27, 2025

Q4 Earnings Estimate for AGIO Issued By HC Wainwright - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Venturi Wealth Management LLC Takes Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

What is HC Wainwright’s Estimate for AGIO Q4 Earnings? - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Agios Bolsters Coffers With $1.1 Bln Milestone Payments Following FDA Approval Of Vorasidenib - RTTNews

Feb 26, 2025
pulisher
Feb 24, 2025

H.C. Wainwright sets $58 target on Agios Pharma stock with Buy rating By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

H.C. Wainwright starts Agios Pharmaceuticals coverage with 'buy' - TradingView

Feb 24, 2025
pulisher
Feb 24, 2025

H.C. Wainwright sets $58 target on Agios Pharma stock with Buy rating - Investing.com India

Feb 24, 2025
pulisher
Feb 21, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Short Interest Down 6.0% in January - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Why Agios Pharmaceuticals' (NASDAQ:AGIO) Earnings Are Weaker Than They Seem - Simply Wall St

Feb 20, 2025
pulisher
Feb 20, 2025

Rare Disease Leader Agios Takes Center Stage at Major Healthcare ConferenceKey Details Inside - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2024 Earnings Call Transcript - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Agios Pharmaceuticals (NASDAQ:AGIO) Downgraded by StockNews.com to "Sell" - MarketBeat

Feb 19, 2025
pulisher
Feb 17, 2025

Agios' Q4 Loss Wider Than Expected, Pyrukynd Drives Revenues - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Agios Pharmaceuticals (NASDAQ: AGIO) Board Member Resignation: David P. Schenkein Steps Down - Defense World

Feb 17, 2025
pulisher
Feb 17, 2025

Here's Why Agios Stock Plummeted More Than 20% on Monday - MSN

Feb 17, 2025
pulisher
Feb 16, 2025

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Agios Pharmaceuticals price target lowered to $74 from $75 at Scotiabank - Yahoo Finance

Feb 15, 2025
pulisher
Feb 15, 2025

Agios Pharmaceuticals announces board resignation - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Long Term Trading Analysis for (AGIO) - Stock Traders Daily

Feb 15, 2025
pulisher
Feb 14, 2025

Agios Pharmaceuticals: Liver Toxicity Issues May Threaten Thalassemia Approval (Rating Downgrade) - Seeking Alpha

Feb 14, 2025

Agios Pharmaceuticals Inc (AGIO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):